Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
2020 · Cell · 563 citations
https://doi.org/10.1016/j.cell.2020.10.043
L
Longping V. Tse
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
10.9K
Citations
33
h-index
52
i10-index
Longping V. Tse is an academic researcher from Saint Louis University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Viral gastroenteritis research and epidemiology & Animal Virus Infections Studies. The author has an h-index of 33, co-authored 74 publications.
ORCID: 0000-0001-7582-8396Papers by this author
worksAdeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery
2019 · Pharmacology & Therapeutics · 160 citations
https://doi.org/10.1016/j.pharmthera.2019.107453
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
2023 · Immunity · 157 citations
https://doi.org/10.1016/j.immuni.2023.02.005
SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia
2024 · Cell Reports · 15 citations
https://doi.org/10.1016/j.celrep.2024.114076
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat